Protamine-Based Insulin Formulations
Physicochemical Stability Advantages
- The American Diabetes Association recommends mixing rapid-acting insulin with NPH, which maintains the pharmacokinetic profile of rapid-acting insulins with only a slight decrease in absorption rate but no reduction in total bioavailability, allowing for prolonged glucose control 1, 2
- When rapid-acting insulin is mixed with NPH, there is no blunting of the onset of action, allowing the rapid-acting component to work as intended, and clinical trials demonstrate that postprandial blood glucose response remains similar whether rapid-acting insulin is mixed with NPH or used separately 1, 2
- The mixture of rapid-acting insulin and NPH can be used immediately or stored for future use without degradation, providing flexibility in treatment plans 1, 2
Superiority Over Zinc-Based Formulations
- Protamine avoids the problematic zinc-binding interactions that occur with lente insulins, which can delay the onset of action unpredictably and make dosing unreliable 1, 2
- Zinc ions present in lente insulins bind with short-acting insulin and delay its onset of action unpredictably, and this binding equilibrium may take up to 24 hours to reach 1, 2
- Mixing phosphate-buffered insulins, such as NPH, with lente insulins causes zinc phosphate precipitation, converting longer-acting insulin to short-acting insulin to an unpredictable extent 1, 2
Clinical Application Guidelines
- The American Diabetes Association specifically endorses protamine-based mixtures for clinical use, recommending that rapid-acting insulin can be mixed with NPH and injected within 15 minutes before a meal 1, 2
- Currently available NPH and short-acting insulin formulations, when mixed, may be used immediately or stored for future use, providing convenience and flexibility in treatment plans 1, 2
- Commercially available pre-mixed insulins using protamine are appropriate when the insulin ratio matches patient requirements, according to the American Diabetes Association 3